Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus

Yongxia Qu1, Victor Adler, Tearina Chu

  • 1Molecular Cardiology, New York Harbor VA Medical Center, Brooklyn, NY 11209, USA.

Insights

Insulin-activated wild-type ras-p21 uniquely activates oocyte maturation through a pathway independent of MEK and MAPK/ERK. This pathway involves T-Cell Origin Protein Kinase (TOPK) and DYRK1A, identified using Xenopus gene arrays.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Oncogenic ras-p21 and wild-type ras-p21 induce oocyte maturation via distinct pathways.
  • While both ras-p21 types interact with raf, insulin-activated wild-type ras-p21's pathway is not fully dependent on MEK and MAP kinase (MAPK/ERK).

Purpose of the Study:

  • To elucidate the raf-dependent but MAPK-independent signaling pathway activated by wild-type ras-p21 during oocyte maturation.
  • To identify novel proteins involved in insulin-induced oocyte maturation.

Main Methods:

  • Gene expression analysis in Xenopus oocytes using a novel gene array.
  • Comparative analysis of oocytes matured with oncogenic ras-p21 versus insulin.
  • Western blot analysis to confirm protein expression levels.

Main Results:

  • Identified T-Cell Origin Protein Kinase (TOPK) and DYRK1A as preferentially expressed in insulin-induced oocyte maturation.
  • Western blots confirmed significantly higher expression of TOPK and DYRK1A in insulin-matured oocytes.
  • Neither TOPK nor DYRK1A are activated by or activate MAPK, suggesting a distinct signaling role.

Conclusions:

  • TOPK and DYRK1A are key components of a unique signaling pathway activated by insulin-induced wild-type ras-p21.
  • These kinases represent potential targets for understanding insulin-mediated oocyte maturation distinct from oncogenic pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...